Fatigue News and Research

RSS

Gut health boost: Functional foods and herbs show promise in tackling SARS-CoV-2 variants

Functional foods and natural herbs have the potential to enhance immune function and maintain gut microbiota diversity. This review explores their role in mitigating the impact of SARS-CoV-2 variants on gut health and overall well-being.

8 Jun 2023

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

Patients suffering from the "most horrible" rare brain tumor are falling through the cracks of mental health provision, University of Essex researchers have found.

8 Jun 2023

New scientific statement details treatment strategies for pediatric cardiomyopathy

Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Jun 2023

Study compares long-term consequences of COVID-19 between patients with rheumatic inflammatory diseases and healthy controls

Researchers used data from a long-term ongoing prospective cohort study in the Netherlands to compare the characteristics of long-COVID in inflammatory rheumatic diseases patients and healthy controls during the period when the SARS-CoV-2 Omicron subvariants, BA.1/BA.2 were dominant.

8 Jun 2023

ATTR amyloidosis cardiomyopathy can be reversed, study reports

Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL (University College London) and the Royal Free Hospital.

7 Jun 2023

UVA scientists discover a key determinant of multiple sclerosis risk

University of Virginia School of Medicine scientists have discovered a key determinant of our risk for multiple sclerosis (MS), advancing efforts to prevent and better treat the disease.

7 Jun 2023

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Fatigue is the symptom that most significantly impacts the daily lives of long Covid patients, and can affect quality of life more than some cancers, finds a new study led by researchers at UCL and the University of Exeter.

7 Jun 2023

Life-changing procedure using new aortic valve device clears way for patient in need of liver transplant and hip replacement

Janice Couch, 62, a retired pre-school teacher from Grand Rapids, Michigan, is finally physically ready to receive two procedures that stand to change her life, thanks to Henry Ford Health interventional cardiologists who paved the way by implanting a new aortic valve device for the first time in the health system's history.

6 Jun 2023

Differences in olfactory abilities in men and women

Researchers compared the responses of men and women to various olfactory stimulations.

6 Jun 2023

HER2-targeted antibody drug conjugate shows encouraging responses, long-lasting clinical benefit in several tumor types

In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit in several tumor types.

5 Jun 2023

Long-haul COVID-19: 1 in 5 still battle symptoms two years post-infection

Up to two years after infection, around 18% of unvaccinated individuals experience post-COVID-19 condition, highlighting higher symptom risk compared to controls. Effective interventions are crucial in mitigating the burden of this condition, and comprehensive clinical trial design considering multiple outcome measures, recovery rates, and symptom heterogeneity is essential for accurate interpretation.

5 Jun 2023

Unraveling the complexity of 'Long-COVID' and its impact on breathing

More than a third of COVID-19 patients experience long-lasting symptoms, known as post-COVID-19 condition or long COVID, with breathlessness being a commonly reported symptom. Pulmonary complications, such as fibrosis and thromboembolic disease, require careful assessment, and non-pharmacological interventions like pulmonary rehabilitation can help manage breathlessness.

5 Jun 2023

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

4 Jun 2023

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years.

2 Jun 2023

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

2 Jun 2023

Men with higher levels of marital satisfaction have lower burnout risk

Workplace burnout is widespread and has a detrimental effect on employee performance, wellbeing, and the overall productivity of the organization.

2 Jun 2023

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Researchers examined the relationship between multidimensional sleep health and post-coronavirus disease 2019 condition.

1 Jun 2023

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Studies on the long-term consequences of COVID-19 (long-COVID) in patients with inflammatory rheumatic diseases (iRD) are scarce.

31 May 2023

$Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine$

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the open access journal Regional Anesthesia & Pain Medicine.

30 May 2023

NJHF grants awards to two Kessler Foundation scientists to advance stroke, spinal cord injury research

Annually, New Jersey Health Foundation (NJHF) invites researchers to submit applications for grants aimed at supporting pilot research projects that exhibit promising potential.

30 May 2023

Fatigue News and Research

Gut health boost: Functional foods and herbs show promise in tackling SARS-CoV-2 variants

Study finds 'most horrible’ rare brain tumor patients falling through the cracks of mental health provision

New scientific statement details treatment strategies for pediatric cardiomyopathy

Study compares long-term consequences of COVID-19 between patients with rheumatic inflammatory diseases and healthy controls

ATTR amyloidosis cardiomyopathy can be reversed, study reports

UVA scientists discover a key determinant of multiple sclerosis risk

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Life-changing procedure using new aortic valve device clears way for patient in need of liver transplant and hip replacement

Differences in olfactory abilities in men and women

HER2-targeted antibody drug conjugate shows encouraging responses, long-lasting clinical benefit in several tumor types

Long-haul COVID-19: 1 in 5 still battle symptoms two years post-infection

Unraveling the complexity of 'Long-COVID' and its impact on breathing

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

Study of immunotherapy for brain cancer metastases shows promising results

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Men with higher levels of marital satisfaction have lower burnout risk

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Long-term consequences of COVID-19 in patients with inflammatory rheumatic diseases

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

NJHF grants awards to two Kessler Foundation scientists to advance stroke, spinal cord injury research

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News